NCT07467330 2026-03-12
Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment
Fujian Cancer Hospital
Phase 3 Recruiting
Clinical Trials
22 trialsNCT07047456 2025-12-23
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
Anhui Provincial Hospital
Phase 3 Recruiting
NCT06520163 2025-12-04
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT06940947 2025-11-20
ETHOS
Norwegian Department of Health and Social Affairs
Phase 3 Recruiting
NCT04776655 2025-10-02
LIBImAb
Azienda USL Reggio Emilia - IRCCS
Phase 3 Recruiting
NCT07185672 2025-09-22
PReCedeNT
Tata Memorial Hospital
Phase 3 Recruiting
NCT05236946 2025-09-10
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Tata Memorial Hospital
Phase 3 Recruiting
NCT05278052 2025-09-10
TARGET-02
Tata Memorial Hospital
Phase 3 Recruiting
NCT06793917 2025-07-20
Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
Fujian Cancer Hospital
Phase 3 Recruiting
NCT07050043 2025-07-03
LEDANG
Hospital Sultanah Bahiyah
Phase 3 Recruiting
NCT06156514 2025-05-28
MICHELE
National Institute of Cancerología
Phase 3 Recruiting
NCT04328948 2025-05-22
ARMADILLO
National Cancer Center, Japan
Phase 3 Recruiting
NCT01785420 2025-04-09
Pre Operative Trastuzumab in Operable Breast Cancer
Tata Memorial Hospital
Phase 3 Recruiting
NCT06565247 2025-03-04
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
Region Västerbotten
Phase 3 Recruiting
NCT06737822 2025-03-04
SurVIC
All India Institute of Medical Sciences, Jodhpur
Phase 3 Recruiting
NCT04214990 2024-12-27
EASTERN
National Cancer Center, Korea
Phase 3 Recruiting
NCT06519266 2024-11-25
SCANDIUM-III
Vastra Gotaland Region
Phase 3 Recruiting
NCT05495152 2024-10-02
Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital
Phase 3 Recruiting
NCT05769868 2024-10-01
CIBERbBECHO
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase 3 Recruiting
NCT04547907 2024-09-20
A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Henan Cancer Hospital
Phase 3 Recruiting
NCT06520176 2024-07-25
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT04138212 2022-08-09
HCHTOG1903
Henan Cancer Hospital
Phase 3 Recruiting